I would recommend thinking about joining the ENIGMA consortium https://enigmaconsortium.org/. It has a very active splicing working group for analysis of variants predicted to affect splicing in cancer predisposition genes. Alexandra Martins is part of that group. The group works collaboratively to avoid duplication, share protocols and SOPs, and discuss new developments.